	自己資本および準備金		日付
Acadia Pharmaceuticals	USD 1.25B	20.68M	2026-03
Adma Biologics	USD 390.32M	86.99M	2026-03
ALKERMES	USD 1.75B	67.76M	2026-03
Alterity Therapeutics Limited	AUD 36.21M	18.58M	2025-12
AstraZeneca	USD 47.33B	1.33B	2026-03
BioCryst Pharmaceuticals	USD -553.84M	434.69M	2026-03
Bristol-Myers Squibb	USD 20.07B	1.6B	2026-03
Cipla	INR 344.32B	15.13B	2026-03
Clal Biotechnology	ILS 121.41M	4.62M	2023-12
Compugen	USD 95.35M	7.38M	2026-03
CSL	USD 18.66B	2.75B	2025-12
Eli Lilly	USD 31.2B	4.66B	2026-03
GlaxoSmithKline	GBP 17.42B	1.05B	2026-03
Grifols	EUR 6.21B	133.12M	2025-12
Halozyme Therapeutics	USD 219.64M	170.82M	2026-03
Ionis Pharmaceuticals	USD 491.41M	2.32M	2026-03
J&J	USD 84.97B	3.78B	2026-06
Merck	USD 45.88B	6.73B	2026-03
Minerva Neurosciences	USD -140.75M	106.17M	2025-12
Neurocrine Biosciences	USD 3.41B	154.3M	2026-03
Novartis	USD 38.93B	7.2B	2026-03
Novavax	USD -144.76M	17.01M	2026-03
Pfizer	USD 90.1B	3.63B	2026-03
Roche Holding	CHF 32.69B	1.11B	2026-06
Sanofi	EUR 72.81B	1.1B	2026-03
Takeda	JPY 7.77T	129.5B	2026-03
Vanda Pharmaceuticals	USD 327.19M	138.81M	2025-12